Curcumin inhibits Cancer-associated fibroblast-driven prostate cancer invasion through MAOA/mTOR/HIF-1α signaling

International Journal of Oncology

Volumn 47, Issue 6, 2015, Pages 2064-2072

  Du, Yuefeng ^a   Long, Qingzhi ^a   Zhang, Lin ^a   Shi, Ying ^b   Liu, Xioagang ^a   Li, Xudong ^a   Guan, Bin ^a   Tian, Yanchao ^a   Wang, Xinyang ^a   Li, Lei ^a   He, Dalin ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Cancer associated fibroblasts; Curcumin; Invasion; Monoamine oxidase A mammalian target of rapamycin hypoxia inducible factor 1 signaling; Prostate cancer

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; CHEMOKINE RECEPTOR CXCR4; CURCUMIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 6; MAMMALIAN TARGET OF RAPAMYCIN; REACTIVE OXYGEN METABOLITE; AMINE OXIDASE (FLAVIN CONTAINING); ANTINEOPLASTIC AGENT; HIF1A PROTEIN, HUMAN; MONOAMINE OXIDASE A, HUMAN; MTOR PROTEIN, HUMAN; TARGET OF RAPAMYCIN KINASE;

ARTICLE; CANCER ASSOCIATED FIBROBLAST; CANCER CELL CULTURE; CANCER INHIBITION; CELL INVASION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CANCER CELL LINE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR INVASION; WESTERN BLOTTING; DRUG EFFECTS; FLUORESCENCE MICROSCOPY; MALE; METABOLISM; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL LINE, TUMOR; CURCUMIN; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROBLASTS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICROSCOPY, FLUORESCENCE; MONOAMINE OXIDASE; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84982732251     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2015.3202     Document Type: Article

References (61)

1. Siegel RL, Miller KD and Jemal A: Cancer statistics, 2015. CA Cancer J Clin 65:5-29, 2015.
2. Partin AW, Kattan MW, Subong EN, Walsh PC, Wojno KJ, Oesterling JE, Scardino PT and Pearson JD: Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multiinstitutional update. JAMA 277:1445-1451, 1997.
3. Bissell MJ and Radisky D: Putting tumours in context. Nat Rev Cancer 1:46-54, 2001.
4. Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2:442-454, 2002.
5. Kalluri R and Zeisberg M: Fibroblasts in cancer. Nat Rev Cancer 6:392-401, 2006.
6. Desmoulière A, Guyot C and Gabbiani G: The stroma reaction myofibroblast: A key player in the control of tumor cell behavior. Int J Dev Biol 48:509-517, 2004.
7. Giannoni E, Bianchini F, Masieri L, Serni S, Torre E, Calorini L and Chiarugi P: Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. Cancer Res 70:6945-6956, 2010.
8. Micke P and Ostman A: Tumour-stroma interaction: Cancerassociated fibroblasts as novel targets in anti-cancer therapy? Lung Cancer 45(Suppl 2):S163-S175, 2004.
9. Sugimoto H, Mundel TM, Kieran MW and Kalluri R: Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol Ther 5:1640-1646, 2006.
10. Begley LA, Kasina S, MacDonald J and Macoska JA: The inflammatory microenvironment of the aging prostate facilitates cellular proliferation and hypertrophy. Cytokine 43:194-199, 2008.
11. Bhowmick NA, Neilson EG and Moses HL: Stromal fibroblasts in cancer initiation and progression. Nature 432:332-337, 2004.
12. Trimboli AJ, Cantemir-Stone CZ, Li F, Wallace JA, Merchant A, Creasap N, Thompson JC, Caserta E, Wang H, Chong JL, et al: Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature 461:1084-1091, 2009.
13. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, Porter D, Hu M, Chin L, Richardson A, et al: Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6:17-32, 2004.
14. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD and Cunha GR: Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59:5002-5011, 1999.
15. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL and Weinberg RA: Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121:335-348, 2005.
16. Crawford Y and Ferrara N: Tumor and stromal pathways mediating refractoriness/resistance to anti-angiogenic therapies. Trends Pharmacol Sci 30:624-630, 2009.
17. Pietras K, Pahler J, Bergers G and Hanahan D: Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting. PLoS Med 5:e19, 2008.
18. Friedl P: Prespecification and plasticity: Shifting mechanisms of cell migration. Curr Opin Cell Biol 16:14-23, 2004.
19. Christofori G: New signals from the invasive front. Nature 441:444-450, 2006.
20. Cowin P, Rowlands TM and Hatsell SJ: Cadherins and catenins in breast cancer. Curr Opin Cell Biol 17:499-508, 2005.
21. Francí C, Takkunen M, Dave N, Alameda F, Gómez S, Rodríguez R, Escrivà M, Montserrat-Sentís B, Baró T, Garrido M, et al: Expression of Snail protein in tumor-stroma interface. Oncogene 25:5134-5144, 2006.
22. Wu JB, Shao C, Li X, Li Q, Hu P, Shi C, Li Y, Chen YT, Yin F, Liao CP, et al: Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis. J Clin Invest 124:2891-2908, 2014.
23. Cheng SC, Quintin J, Cramer RA, Shepardson KM, Saeed S, Kumar V, Giamarellos-Bourboulis EJ, Martens JH, Rao NA, Aghajanirefah A, et al: mTOR- and HIF-1a-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 345:1250684, 2014.
24. Aggarwal BB, Sundaram C, Malani N and Ichikawa H: Curcumin: The Indian solid gold. Adv Exp Med Biol 595:1-75, 2007.
25. Ammon HP and Wahl MA: Pharmacology of Curcuma longa. Planta Med 57:1-7, 1991.
26. Wilken R, Veena MS, Wang MB and Srivatsan ES: Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer 10:12, 2011.
27. Beevers CS, Zhou H and Huang S: Hitting the golden TORget: Curcumin's effects on mTOR signaling. Anticancer Agents Med Chem 13:988-994, 2013.
28. Beevers CS, Chen L, Liu L, Luo Y, Webster NJ and Huang S: Curcumin disrupts the mammalian target of rapamycin-raptor complex. Cancer Res 69:1000-1008, 2009.
29. Yu S, Shen G, Khor TO, Kim JH and Kong AN: Curcumin inhibits Akt/mammalian target of rapamycin signaling through protein phosphatase-dependent mechanism. Mol Cancer Ther 7:2609-2620, 2008.
30. Schnaitman C, Erwin VG and Greenawalt JW: The submitochondrial localization of monoamine oxidase. An enzymatic marker for the outer membrane of rat liver mitochondria. J Cell Biol 32:719-735, 1967.
31. Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative C (T) method. Nat Protoc 3:1101-1108, 2008.
32. Chiarugi P, Pani G, Giannoni E, Taddei L, Colavitti R, Raugei G, Symons M, Borrello S, Galeotti T and Ramponi G: Reactive oxygen species as essential mediators of cell adhesion: The oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. J Cell Biol 161:933-944, 2003.
33. Mantovani A: Role of inflammatory cells and mediators in tumor invasion and metastasis. Cancer Metastasis Rev 29:241, 2010.
34. Pani G, Galeotti T and Chiarugi P: Metastasis: Cancer cell's escape from oxidative stress. Cancer Metastasis Rev 29:351-378, 2010.
35. Giannoni E, Fiaschi T, Ramponi G and Chiarugi P: Redox regulation of anoikis resistance of metastatic prostate cancer cells: Key role for Src and EGFR-mediated pro-survival signals. Oncogene 28:2074-2086, 2009.
36. Khandrika L, Kumar B, Koul S, Maroni P and Koul HK: Oxidative stress in prostate cancer. Cancer Lett 282:125-136, 2009.
37. Kim HI, Huang H, Cheepala S, Huang S and Chung J: Curcumin inhibition of integrin (alpha6beta4)-dependent breast cancer cell motility and invasion. Cancer Prev Res (Phila) 1:385-391, 2008.
38. Buhrmann C, Mobasheri A, Busch F, Aldinger C, Stahlmann R, Montaseri A and Shakibaei M: Curcumin modulates nuclear factor kappaB (NF-kappaB)-mediated inflammation in human tenocytes in vitro: Role of the phosphatidylinositol 3-kinase/Akt pathway. J Biol Chem 286:28556-28566, 2011.
39. Shehzad A, Lee J and Lee YS: Curcumin in various cancers. Biofactors 39:56-68, 2013.
40. Cheng TS, Chen WC, Lin YY, Tsai CH, Liao CI, Shyu HY, Ko CJ, Tzeng SF, Huang CY, Yang PC, et al: Curcumin-targeting pericellular serine protease matriptase role in suppression of prostate cancer cell invasion, tumor growth, and metastasis. Cancer Prev Res (Phila) 6:495-505, 2013.
41. Zhao H, Nolley R, Chen Z, Reese SW and Peehl DM: Inhibition of monoamine oxidase A promotes secretory differentiation in basal prostatic epithelial cells. Differentiation 76:820-830, 2008.
42. Chen X, Cheng H, Pan T, et al: mTOR regulate EMT through RhoA and Rac1 pathway in prostate cancer. Mol Carcinog 54:1086-1095, 2014.
43. Liu L, Li F, Cardelli JA, Martin KA, Blenis J and Huang S: Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways. Oncogene 25:7029-7040, 2006.
44. Gulhati P, Bowen KA, Liu J, Stevens PD, Rychahou PG, Chen M, Lee EY, Weiss HL, O'Connor KL, Gao T, et al: mTORCl and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. Cancer Res 71:3246-3256, 2011.
45. Cannito S, Novo E, Compagnone A, Valfrè Di Bonzo L, Busletta C, Zamara E, Paternostro C, Povero D, Bandino A, Bozzo F, et al: Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells. Carcinogenesis 29:2267-2278, 2008.
46. Yang MH and Wu KJ: TWIST activation by hypoxia inducible factor-1 (HIF-1): Implications in metastasis and development. Cell Cycle 7:2090-2096, 2008.
47. Calvani M, Rapisarda A, Uranchimeg B, Shoemaker RH and Melillo G: Hypoxic induction of an HIF-1alpha-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells. Blood 107:2705-2712, 2006.
48. Stasinopoulos I, O'Brien DR and Bhujwalla ZM: Inflammation, but not hypoxia, mediated HIF-1alpha activation depends on COX-2. Cancer Biol Ther 8:31-35, 2009.
49. Mori K, Shibanuma M and Nose K: Invasive potential induced under long-term oxidative stress in mammary epithelial cells. Cancer Res 64:7464-7472, 2004.
50. Lei J, Huo X, Duan W, Xu Q, Li R, Ma J, Li X, Han L, Li W, Sun H, et al: a-Mangostin inhibits hypoxia-driven ROS-induced PSC activation and pancreatic cancer cell invasion. Cancer Lett 347:129-138, 2014.
51. Chandel NS, McClintock DS, Feliciano CE, Wood TM, Melendez JA, Rodriguez AM and Schumacker PT: Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: A mechanism of O2 sensing. J Biol Chem 275:25130-25138, 2000.
52. Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC and Schumacker PT: Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci USA 95:11715-11720, 1998.
53. Semenza GL: Oxygen homeostasis. Wiley Interdiscip Rev Syst Biol Med 2:336-361, 2010.
54. Youn SW, Lee SW, Lee J, Jeong HK, Suh JW, Yoon CH, Kang HJ, Kim HZ, Koh GY, Oh BH, et al: COMP-Ang1 stimulates HIF-1a-mediated SDF-1 overexpression and recovers ischemic injury through BM-derived progenitor cell recruitment. Blood 117:4376-4386, 2011.
55. Li X, Ma Q, Xu Q, Liu H, Lei J, Duan W, Bhat K, Wang F, Wu E and Wang Z: SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial-mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway. Cancer Lett 322:169-176, 2012.
56. Rokavec M, Öner MG, Li H, Jackstadt R, Jiang L, Lodygin D, Kaller M, Horst D, Ziegler PK, Schwitalla S, et al: IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis. J Clin Invest 124:1853-1867, 2014.
57. Zhou DY, Ding N, Du ZY, Cui XX, Wang H, Wei XC, Conney AH, Zhang K and Zheng X: Curcumin analogues with high activity for inhibiting human prostate cancer cell growth and androgen receptor activation. Mol Med Rep 10:1315-1322, 2014.
58. Dorai T, Diouri J, O'Shea O and Doty SB: Curcumin inhibits prostate cancer bone metastasis by up-regulating bone morphogenic protein-7 in vivo. J Cancer Ther 5:369-386, 2014.
59. Eom DW, Lee JH, Kim YJ, et al: Synergistic effect of curcumin on epigallocatechin gallate-induced anticancer action in PC3 prostate cancer cells. BMB Rep 48:461-466, 2015.
60. Wang P, Wang B, Chung S, Wu Y, Henning SM and Vadgama JV: Increased chemopreventive effect by combining arctigenin, green tea polyphenol and curcumin in prostate and breast cancer cells. RSC Advances 4:35242-35250, 2014.
61. Mohandas KM and Desai DC: Epidemiology of digestive tract cancers in India. V. Large and small bowel. Indian J Gastroenterol 18:118-121, 1999.